Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials ...Middle East

Two phase 3 trials of the once-monthly SEL-212 in refractory gout achieved and maintained serum uric acid MDedge News

Hence then, the article about uricase based gout drug meets endpoints in phase 3 trials was published today ( Wednesday 07/06/2023 - 10:24 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Uricase-Based Gout Drug Meets Endpoints in Phase 3 Trials )

Also on site :

• After the Fire, Hope Valley Faces Its First Reckoning in 'When Calls the Heart' Season 13 Episode 3
• Merz criticizes Germans for getting sick too often
• Simone Biles Stuns in Jonathan Owens-Inspired Outfit for NFL Playoff Game